Abstract
Left atrial appendage thrombi (LAAT) are the main cause of stroke, transit ischemic attack and systemic thrombosis in patients with atrial fibrillation (AF). Especially, movable type LAAT is high risk for thromboembolic events, and requires an urgent powerful antithrombotic therapy. However, it
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
